25 Mar 2013
Byetta Users At Risk of Thyroid Cancer
Byetta, was approved for use by the U.S. food and Drug Administration (FDA) in 2005. As soon as it became available, Byetta was marketed as a means to alleviate symptoms of type 2 diabetes by improving the body’s ability to produce and use insulin. It was not to be used in conjunction with insulin replacement therapy. In fact, it was sold as a me...
